SEC 13F Intelligence

New England Research & Management, Inc. / JNJ

New England Research & Management, Inc.’s Johnson & Johnson Position

Does New England Research & Management, Inc. own Johnson & Johnson (JNJ)? Yes — 29.5K shares worth $7M (+2.92% of its 13F portfolio) as of Q2 2026, up from 28.8K shares the prior filed quarter.

Position Value
$7M
Q2 2026
Shares
29.5K
% of Portfolio
+2.92%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $5MQ2 ’19: $5MQ3 ’19: $4MQ4 ’19: $5MQ4 ’19Q2 ’20: $5MQ3 ’20: $5MQ4 ’20: $6MQ1 ’21: $4MQ1 ’21Q2 ’21: $4MQ3 ’21: $4MQ4 ’21: $4MQ1 ’22: $5MQ1 ’22Q2 ’22: $5MQ3 ’22: $5MQ4 ’22: $5,148Q1 ’23: $4,733Q1 ’23Q2 ’23: $5,067Q3 ’23: $4,724Q4 ’23: $4,685Q1 ’24: $4,718Q1 ’24Q2 ’24: $4,175Q3 ’24: $4,586Q4 ’24: $3,999Q1 ’25: $4,933Q1 ’25Q2 ’25: $4,546Q3 ’25: $5MQ4 ’25: $6MQ1 ’26: $7MQ1 ’26Q2 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 202629.5K$7M+2.92%
Q1 202628.8K$7M+2.98%
Q4 202529.2K$6M+2.65%
Q3 202529.4K$5M+2.50%
Q2 202529.8K$4,546+2.16%
Q1 202529.7K$4,933+2.51%
Q4 202427.7K$3,999+2.03%
Q3 202428.3K$4,586+2.15%
Q2 202428.6K$4,175+2.01%
Q1 202429.8K$4,718+2.32%
Q4 202329.9K$4,685+2.48%
Q3 202330.3K$4,724+2.69%
Q2 202330.6K$5,067+2.94%
Q1 202330.5K$4,733+2.78%
Q4 202229.1K$5,148+2.96%
Q3 202229.5K$5M+3.04%
Q2 202227.3K$5M+2.82%
Q1 202226.0K$5M+2.39%
Q4 202124.9K$4M+2.06%
Q3 202125.3K$4M+2.14%
Q2 202125.3K$4M+2.16%
Q1 202125.3K$4M+2.28%
Q4 202035.0K$6M+3.41%
Q3 202035.3K$5M+3.81%
Q2 202034.9K$5M+3.51%
Q4 201933.1K$5M+3.24%
Q3 201934.7K$4M+3.25%
Q2 201932.8K$5M+3.10%
Q1 201934.9K$5M+3.29%
Q4 201835.7K$5M+3.63%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See New England Research & Management, Inc.’s full portfolio or all institutional holders of JNJ.